The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale
Abstract
The Sheehan Disability Scale (SDS) is a patient-rated, discretized analog measure of functional disability in work, social, and family life. Its increasing use in clinical trials in psychiatry suggests a need to assess its responsiveness and interpretability. In this paper we identify and review studies in which the SDS was used as a treatment outcome measure. Our objectives are (i) to evaluate the sensitivity of the SDS to treatment effects and (ii) to examine potential thresholds or cutoff scores for remission and response. Studies for the review were retrieved from the National Library of Medicine's PubMed database (1966 to 21 March 2007) and other sources. All studies had to use the SDS, be double-blind, controlled or large open-label trials in English. Studies assessing nonpharmacological treatments, long-term trials (>12 weeks), small n trials (less than 20 patients per treatment arm) and trials for conditions other than one of the anxiety disorders, depression, or premenstrual dysphoric disorder were excluded. Extracted data included the diagnostic target of treatment, n, study design, and method of analysis. Initial, endpoint and/or mean change scores were extracted from tables, text, or extrapolated from figures. In all, 37 studies meeting the inclusion criteria were retrieved and reviewed. All of the studies treated the SDS as a numeric scale and analyzed mean change or endpoint differences with parametric statistics. Three provided additional outcome data using nonparametric response or remission criteria. Overall, the SDS performed well in discriminating between active and inactive treatments. The results indicate that the SDS is sensitive to treatment effects. To establish reliable and valid cutoff scores for remission and response, there is a need to supplement parametric analyses using mean change and endpoint differences with nonparametric analyses showing the percentage meeting specified response and remission criteria. In addition, the percentages with endpoint scores of zero should be reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · cited 2×
“…Adjustment Scale (SAS) consisted of over 50 items (Weissman and Bothwell, 1976) whereas the Medical Outcome Study (MOS) SF-36 had 36 items (Ware and Sherbourne, 1992) and the Global Assessment Scale required differentiating among 21 items to produce a score from 0 to 100 (Endicott et al., 1976).”
MethodJaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.262.7.914 · Cited by 2,808
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
Cited by
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
The Use and Effectiveness of Mobile Apps for Depression: Results From a Fully Remote Clinical Trial
Arean, P. A., Hallgren, K. A., Jordan, J. T., Gazzaley, A., Atkins, D. C., Heagerty, P. J., & Anguera, J. A. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.6482 · Cited by 376
McKnight, P. E., & Kashdan, T. B. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.005 · Cited by 400
“Only one item specifically addresses social functioning, however, most researchers use all three items together to reflect overall disability (Sheehan & Sheehan, 2008).”
BackgroundSymptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
Havervall, S., Rosell, A., Phillipson, M., Mangsbo, S. M., Nilsson, P., Hober, S., & Thålin, C. (2021) · JAMA · doi:10.1001/jama.2021.5612 · Cited by 388
Etzelmueller, A., Vis, C., Karyotaki, E., Baumeister, H., Titov, N., Berking, M., Cuijpers, P., Riper, H., & Ebert, D. D. (2020) · Journal of Medical Internet Research · doi:10.2196/18100 · Cited by 356
“Information is depicted in Multimedia Appendix 5 [64-101] and Multimedia Appendix 6 [102-120] on the iCBT service–related characteristics.”
BackgroundFunctional impairment in social anxiety disorder
Aderka, I. M., Hofmann, S. G., Nickerson, A., Hermesh, H., Gilboa-Schechtman, E., & Marom, S. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.01.003 · Cited by 343
McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Restoring function in major depressive disorder: A systematic review
Sheehan, D. V., Nakagome, K., Asami, Y., Pappadopulos, E. A., & Boucher, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.029 · Cited by 182
Self-citationMontgomery, S. A., Nielsen, R. Z., Poulsen, L. H., & Häggström, L. (2014) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2424 · Cited by 143
Zaki, N., Chen, L., Lane, R., Doherty, T., Drevets, W. C., Morrison, R. L., Sanacora, G., Wilkinson, S. T., Popova, V., & Fu, D.-J. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01577-5 · Cited by 137
Rief, W., Burton, C., Frostholm, L., Henningsen, P., Kleinstäuber, M., Kop, W. J., Löwe, B., Martin, A., Malt, U., Rosmalen, J., et al. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000502 · Cited by 129
Turkoz, I., Alphs, L., Singh, J., Jamieson, C., Daly, E., Shawi, M., Sheehan, J. J., Trivedi, M. H., & Rush, A. J. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13260 · Cited by 104
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
“Improvement in function and quality of life often lags behind symptom remission in patients with MDD (Bech, 2005; Sheehan and Sheehan, 2008; IsHak et al., 2011).”
BackgroundMethodJohns, L. C., Oliver, J. E., Khondoker, M., Byrne, M., Jolley, S., Wykes, T., Joseph, C., Butler, L., Craig, T., & Morris, E. M. J. (2016) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2015.10.001 · Cited by 97
Buhmann, C. B., Nordentoft, M., Ekstroem, M., Carlsson, J., & Mortensen, E. L. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150961 · Cited by 92
Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Agrawal, M., Richards, W., Beaussant, Y., Shnayder, S., Ameli, R., Roddy, K., Stevens, N., Richards, B., Schor, N., Honstein, H., et al. (2024) · Cancer · doi:10.1002/cncr.35010 · Cited by 88
Asnis, G. M., Bose, A., Gommoll, C. P., Chen, C., & Greenberg, W. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08197 · Cited by 83
Culpepper, L., Muskin, P. R., & Stahl, S. M. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.07.001 · Cited by 77
Examining the short-term anxiolytic and antidepressant effect of Floatation-REST
Feinstein, J. S., Khalsa, S. S., Yeh, H.-W., Wohlrab, C., Simmons, W. K., Stein, M. B., & Paulus, M. P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0190292 · Cited by 79
Retz, W., Rösler, M., Ose, C., Scherag, A., Alm, B., Philipsen, A., Fischer, R., Ammer, R., & The Study Group (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.540257 · Cited by 79
Bakish, D., Bose, A., Gommoll, C., Chen, C., Nunez, R., Greenberg, W. M., Liebowitz, M., & Khan, A. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130040 · Cited by 70
Yoga as an adjunct treatment for alcohol dependence: a pilot study
Hallgren, M., Romberg, K., Bakshi, A.-S., & Andréasson, S. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.03.003 · Cited by 67
Rothschild, A. J., Raskin, J., Wang, C.-N., Marangell, L. B., & Fava, M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.08.008 · Cited by 59
Larsen, S. E., Bellmore, A., Gobin, R. L., Holens, P., Lawrence, K. A., & Pacella-LaBarbara, M. L. (2019) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2019.01.008 · Cited by 57
Carlsson, J., Sonne, C., Vindbjerg, E., & Mortensen, E. L. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.015 · Cited by 53
Interpreter-mediated psychotherapy with trauma-affected refugees – A retrospective cohort study
Sander, R., Laugesen, H., Skammeritz, S., Mortensen, E. L., & Carlsson, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.058 · Cited by 46
Ma, J., Yank, V., Lv, N., Goldhaber-Fiebert, J. D., Lewis, M. A., Kramer, M. K., Snowden, M. B., Rosas, L. G., Xiao, L., & Blonstein, A. C. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.06.010 · Cited by 45
Sheehan, D. V., Harnett-Sheehan, K., Hidalgo, R. B., Janavs, J., McElroy, S. L., Amado, D., & Suppes, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.016 · Cited by 42
Self-citationTeo, S. H., Fong, K. N. K., Chen, Z., & Chung, R. C. K. (2020) · Brain Injury · doi:10.1080/02699052.2020.1802668 · Cited by 39
Florea, I., Danchenko, N., Brignone, M., Loft, H., Rive, B., & Abetz-Webb, L. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.08.008 · Cited by 35
Jolley, S., Johns, L. C., O’Donoghue, E., Oliver, J., Khondoker, M., Byrne, M., Butler, L., De Rosa, C., Leal, D., McGovern, J., et al. (2020) · British Journal of Clinical Psychology · doi:10.1111/bjc.12265 · Cited by 26
Weiss, C., Meehan, S. R., Brown, T. M., Gupta, C., Mørup, M. F., Thase, M. E., McIntyre, R. S., & Ismail, Z. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00380-4 · Cited by 25
Litz, B. T., Yeterian, J., Berke, D., Lang, A. J., Gray, M. J., Nienow, T., Frankfurt, S., Harris, J. I., Maguen, S., & Rusowicz-Orazem, L. (2024) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000873 · Cited by 25
Sex differences in the mediators of functional disability in Major Depressive Disorder
Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Cha, D. S., Lee, Y., Fus, D., & McIntyre, R. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.025 · Cited by 22
Zhou, Y., Wang, C., Lan, X., Zheng, W., Li, H., Chao, Z., McIntyre, R. S., & Ning, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.032 · Cited by 19
Zeljic, K., Zhang, Y., Qiu, X., Chen, X., Gong, H., Jin, H., Zhang, C., & Storch, E. A. (2020) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.34.1.58 · Cited by 15
Richards, C., Iosifescu, D. V., Mago, R., Sarkis, E., Reynolds, J., Geibel, B., & Dauphin, M. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117722998 · Cited by 14
Sorsdahl, K., Stein, D. J., Pasche, S., Jacobs, Y., Kader, R., Odlaug, B., Richter, S., Myers, B., & Grant, J. E. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00209-3 · Cited by 11
Loebel, A., Siu, C., Rajagopalan, K., Pikalov, A., Cucchiaro, J., & Ketter, T. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.033 · Cited by 11
Zhang, C. C., McGuire, J. F., Qiu, X., Jin, H., Li, Z., Cepeda, S., Goodman, W. K., & Storch, E. A. (2017) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2016.11.006 · Cited by 7
Sundström, C., Hadjistavropoulos, H., Wilhelms, A., Keough, M., & Schaub, M. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02506-2 · Cited by 7
Gandarela, L., de A. Sampaio, T. P., Marçal, L., Burdmann, E. A., Neto, F. L., & Bernik, M. A. (2024) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2024.100779 · Cited by 6
“Functional impairment was measured using the Sheehan Disability Scale (Sheehan and Sheehan, 2008), a three-item, self-rated scale designed to assess family, work, and social impairment in the previous week.”
MethodWang, X., Fan, Y., Li, G., & Li, H. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000350 · Cited by 4
“, 2007) and Sheehan Disability Scale (SDS) assessments (Sheehan and Sheehan, 2008).”
BackgroundMethodLange, A. B., Mortensen, E. L., Palic, S., Sonne, C. K., & Carlsson, J. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100586 · Cited by 3
Barhoma, M., Carlsson, J., & Sonne, C. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2324357 · Cited by 1
Metadata
- Authors
- Sheehan, K. H., & Sheehan, D. V.
- Venue
- International Clinical Psychopharmacology
- Published
- 2008-03
- Volume
- 23
- Issue
- 2
- Pages
- 70-83
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2084779737
- Cited by
- 467
- References
- 96
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.